Zobrazeno 1 - 10
of 29
pro vyhledávání: '"High grade non–muscle-invasive bladder cancer"'
Autor:
Christine G.J.I. van Straten, Christien Caris, Marc-Oliver Grimm, Marc Colombel, Tim Muilwijk, Luis Martínez-Piñeiro, Marko M. Babjuk, Levent N. Türkeri, Joan Palou, Anup Patel, Anders S. Bjartell, Wim P.J. Witjes, Antoine G. van der Heijden, Lambertus A.L.M. Kiemeney
Publikováno v:
European Urology Open Science, Vol 56, Iss , Pp 15-24 (2023)
Background: Adverse events induced by intravesical bacillus Calmette-Guérin (BCG) to treat high-grade non–muscle-invasive bladder cancer (NMIBC) often lead to treatment discontinuation. The EAU-RF NIMBUS trial found a reduced number of standard-do
Externí odkaz:
https://doaj.org/article/da507eeb842949a392f422cfef50f3e2
Autor:
Francesco Soria, David D'Andrea, Maurizio Barale, Kilian M. Gust, Francesca Pisano, Simone Mazzoli, Matteo De Bellis, Matteo Rosazza, Simone Livoti, Daniele Dutto, Beatrice Lillaz, Benjamin Pradere, Marco Moschini, Dietmar Tamandl, Shahrokh F. Shariat, Paolo Gontero
Publikováno v:
European Urology Open Science, Vol 50, Iss , Pp 17-23 (2023)
Background: Skeletal muscle loss (sarcopenia) has been linked to cancer cachexia and can predict survival in several tumors, including advanced genitourinary malignancies. Objective: To investigate the predictive and prognostic role of sarcopenia in
Externí odkaz:
https://doaj.org/article/25463d18c0b7481da399c809784e06bd
Autor:
Marco Paciotti, Paolo Casale, Piergiuseppe Colombo, Vittorio Fasulo, Alberto Saita, Giovanni Lughezzani, Roberto Contieri, Nicolò Maria Buffi, Massimo Lazzeri, Giorgio Guazzoni, Rodolfo Hurle
Publikováno v:
European Urology Open Science, Vol 26, Iss , Pp 64-71 (2021)
Background: En bloc resection (ERBT) is a valid alternative to piecemeal resection for non–muscle-invasive bladder cancer (NMIBC), guaranteeing pathological outcomes. However, very few studies investigated long-term oncological outcomes of ERBT. Ob
Externí odkaz:
https://doaj.org/article/841e839f64db428a840fdeef11f74a51
Publikováno v:
World Journal of Surgical Oncology, Vol 16, Iss 1, Pp 1-15 (2018)
Abstract Background High-grade non-muscle-invasive bladder cancer is superficial; nonetheless, it is an aggressive cancer. Proper management strategy selection following transurethral resection between bladder preservation (BP) and radical cystectomy
Externí odkaz:
https://doaj.org/article/92b62592b10b4ca4a795448063167f0e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alberto Saita, Vittorio Fasulo, Giovanni Lughezzani, Paolo Casale, Massimo Lazzeri, Marco Paciotti, Giorgio Guazzoni, Piergiuseppe Colombo, Nicolò Maria Buffi, Roberto Contieri, Rodolfo Hurle
Publikováno v:
European Urology Open Science, Vol 26, Iss, Pp 64-71 (2021)
European Urology Open Science
European Urology Open Science
Background En bloc resection (ERBT) is a valid alternative to piecemeal resection for non–muscle-invasive bladder cancer (NMIBC), guaranteeing pathological outcomes. However, very few studies investigated long-term oncological outcomes of ERBT. Obj
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Giuseppe Palermo, Pierfrancesco Bassi, Emilio Sacco, Luca Di Gianfrancesco, M. Ragonese, Marco Racioppi
Publikováno v:
Journal of Geriatric Oncology. 9:507-512
To evaluate the efficacy and safety of a tailored endovesical immunotherapy protocol with biweekly BCG for elderly Patients with high risk non muscle invasive bladder cancer (HG-NMIBC).We retrospectively evaluated data from 200 patients older than 80
Autor:
Maurice P. Zeegers, Richard T. Bryan, Nicholas D. James, Anthony A. Fryer, John R Glossop, Richard D. Emes, Kar Keung Cheng, Christopher Luscombe, Charles A. Mein, Adam J. Devall, William E. Farrell, Lyndon Gommersall, Mark O. Kitchen
Publikováno v:
Epigenetics, 11(3), 237-246. Landes Bioscience
High-grade non-muscle invasive bladder cancer (HG-NMIBC) is a clinically unpredictable disease with greater risks of recurrence and progression relative to their low-intermediate-grade counterparts. The molecular events, including those affecting the
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.